Abstract
The last decade has witnessed an exponential proliferation of radiosurgery facilities in the United States and around the globe, and consequently, several tens of thousands of patients have undergone this procedure for a variety of intracranial and skull-base abnormalities. Since brain metastases represent the most common intracranial neoplasm, these have become a common target for radiosurgery. We present a review paper summarizing the major issues surrounding the management of brain metastases as well as an English-language literature review of 20 independent reports, using either γ-knife or linear accelerator-based radiosurgery, with >1250 patients and >2100 lesions available for analysis. Variable reporting in the studies precludes a definitive analysis and comparison of all factors in a rigorous statistical fashion, but the composite data reveal an average local control rate of 83% and a median survival of 9.6 months, which are comparable to those in recent surgical reports. Prognostic factors for survival are beginning to be unraveled, and the most important ones appear to be the presence of fewer than three lesions, controlled extracranial disease, and Karnofsky performance score. The exact impact of dose has not been clarified, but a dose–response relationship, especially for ≥18 Gy, is emerging. The role of whole-brain radiotherapy remains unresolved; it may enhance local control but does not convincingly improve survival and, in some series, is associated with an increased risk of late complications, which appear to be less than 5% on average. The concerns regarding chronic steroid dependance and increased intracranial edema do not appear to be a common problem. With such a large base of uncontrolled evidence, this is an opportune time for conducting and completing randomized trials to validate these observations.
Similar content being viewed by others
REFERENCES
Posner JB: Management of central nervous system metastases. Semin Oncol 4:81–91, 1977
Hazra T, Mullins GN, Lott S: Management of cerebral metastases from bronchogenic carcinoma. Johns Hopkins Med J 130:377–383, 1972
Posner JB: Diagnosis and treatment of metastases to the brain. Clin Bull 4:47–57, 1974
Zimm S, Wampler GL, Stablein D, Hazra T, Young HF: Intracerebral metastases in solid tumor patients. Natural history and results of treatment. Cancer 48:384–394, 1981
Kofman S, Garvin J, Nagamani D: Treatment of cerebral metastases from breast carcinoma with prednisilone. JAMA 163:1473–1476, 1957
MacDonell A, Potter PE, Leslie RA: Localized changes in blood brain barrier permeability following the administration of anti-neoplastic drugs. Cancer Res 38:2930–2934, 1978
Weissman DE. Glucocorticoid treatment for brain metastases and epidural spinal cord compression, a review. J Clin Oncol 6:543–550, 1988
Chao JH, Phillips R, Nickson JJ: Roentgen-ray therapy of cerebral metastases. Cancer 7:682–689, 1954
Borgelt B, Gelber R, Kramer S, Brady LW, Chang CH, Davis LW, et al.: The palliation of brain metastases. Final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6:1–8, 1980
Diener-West M, Dobbins TW, Phillips TL, Nelson DF: Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG Study 7916. Int J Radiat Oncol Biol Phys 16:669–673, 1989
Swift PS, Phillips T, Martz K, Wara W, Mohiuddin M, Chang CH, et al.: CT characteristics of patients with brain metastases treated in RTOG study 79–16. Int J Radiat Oncol Biol Phys 25: 209–214, 1993
Coia LR, Hanks GE, Martz K, Steinfield A, Diamond JJ, Kramer S: Practice patterns of palliative care for the United States 1984–1985. Int J Radiat Oncol Biol Phys 14:1261–1269, 1988
Epstein BE, Scott CB, Sause WT, Rotman M, Sneed PK, Janjan NA, et al.: Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 Gy and greater. Results of Radiation Therapy Oncology Group 85–28. Cancer 71:1362–1367, 1993
Smalley SR, Schray MF, Laws ER Jr, O'Fallon JR: Adjuvant radiation therapy after surgical resection of solitary brain metastases: Association with pattern of failure and survival. Int J Radiat Oncol Biol Phys 13:1611–1616, 1987
Moser RP, Johnson ML: Surgical management of brain metastases: How aggressive should we be? Oncology 3:123–127, 1989
Noordijk EM, Vecht CJ, Haaxma-Reiche J, Padberg, GW, Voormolen JHC, Hoekstra FH, et al.: The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 29:711–717, 1994
Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Marayuma Y, Kryscio RJ, et al.: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500, 1990
Engebraaten O, Schwachenwald R, Valen HEO: Effects of high and low single dose irradiation on glioma spheroid invasion into normal rat brain tissue in vitro. Anticancer Res 12:1501–1506, 1992
Nieder C, Berberich W, Nestle U, Niewald M, Walter K, Schnabel K, et al.: Relation between local result and total dose of radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys 33: 349–355, 1995
Sturm V, Kober B, Hover KH, Schlegel W, Boesecke R, Pastyr O, et al.: Stereotactic percutaneous single dose irradiation of brain metastases with a linear accelerator. Int J Radiat Oncol Biol Phys 13:279–282, 1987
Voges J, Treuer H, Schlegel W, Pastyr O, Muller RP, Lorenz WJ, et al.: Linac-radiosurgery in brain metastases. Acta Neurochir 122: 158, 1993
Alexander E, Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM, et al.: Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 87:34–40, 1995
Bindal AK, Bindal RK, Hess KR, Shiu, A, Hassenbusch SJ, Shi WM, et al.: Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg 84:748–754, 1996
Breneman JC, Warnick RE, Albright RE, Kukiatinant N, Shaw J, Armin D, et al.: Stereotactic radiosurgery for the treatment of brain metastases: Results of a single institution series. Cancer 79: 551–557, 1996
Caron JL, Souhami L, Podgorsak EB: Dynamic stereotactic radiosurgery in the palliative treatment of cerebral metastatic tumors. J Neuroncol 12:173–179, 1992
Chamberlain MC, Kormanik P, Barba D, Fuller BG, Smith DE, Shea WMC, et al.: Stereotactic radiosurgery for metastatic brain tumors. Int J Oncol 8:617–624, 1996
Davey P, O'Brien PF, Schwartz ML, Cooper BW: A phase I/II study of salvage radiosurgery in the treatment of recurrent brain metastases. Br J Neurosurg 8:717–723, 1994
DeSalles AA, Hariz M, Bajada CL, Goetsch St., Bergenheim T, Selch M, et al.: Comparison between radiosurgery and stereotactic fractionated radiation for the treatment of brain metastases. Acta Neurochir Suppl 58:115–118, 1993
Engenhart R, Kimmig BN, Hover K, Wowra B, Romahn J, Lorenz WJ, et al.: Long term follow-up for brain metastases treated by percutaneous single high dose radiation. Cancer 71:1353–1361, 1993
Joseph J, Adler JR, Cox RS, Hancock SL: Linear acceleratorbased stereotactic radiosurgery for brain metastases: The influence of number of lesions on survival. J Clin Oncol 14:1085–1092, 1996
Mehta MP, Rozental JM, Levin AB, Mackie TR, Kubsad SS, Gehring MA, et al.: Defining the role of stereotactic radiosurgery in the management of brain metastases. Int J Radiat Oncol Biol Phys 24:619–625, 1992
Shirato H, Takamura A, Tomita M, Suzuki K, Nishioka T, Isu T, et al.: Stereotactic irradiation without whole-brain irradiation for single brain metastases. Int J Radiat Oncol Biol Phys 37:385–391, 1997
Sturm V, Kimmig B, Engenhardt R, Schlegel W, Pastyr O, Treuer H, et al.: Radiosurgical treatment of cerebral metastases. Stereo Function Neurosurg 57:7–10, 1991
Valentino V: The results of radiosurgical management of 139 single cerebral metastases. Acta Neurochir Suppl 63:95–100, 1995
Voges J, Treuer H, Erdmann J, Schlegel W, Pastyr O, Muller RP, Sturm V: Linac radiosurgery in brain metastases. Acta Neurochir Suppl 62:72–76, 1994
Kihlstrom L, Karlsson B, Lindquist C: Gamma Knife surgery for cerebral metastases. Implications for survival based on 16 years experience. Stereo Funct Neurosurg 61:45–50, 1993
Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EG, et al.: A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28:797–802, 1994
Jokura H, Takahashi K, Kayama T, Yoshimoto T: Gamma knife radiosurgery of a series of only minimally selected metastatic brain tumours. Acta Neurochir 62:77–82, 1994
Kida Y, Kobayashi T, Tanaka T: Radiosurgery of the metastatic brain tumours with gamma-knife. Acta Neurochir 63:89–94, 1995
Whang CJ, Kwon Y: Gamma knife radiosurgery for malignant tumors. J Kor Med Sci 10:379–387, 1995
Shiau CY, Sneed PK, Shu HK, Lamborn KR, McDermott MW, Chang S, et al.: Radiosurgery for brain metastases: Relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 37:375–383, 1997
Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al.: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751, 1997
Auchter RM, Lamond JP, Alexander E, Buatti JM, Chappell R, Friedman WA, et al.: A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 35:27–35, 1996
Shu HK, Sneed PK, Shiau CY, McDermott MW, Lamborn KR, Park E, et al.: Factors influencing survival after gamma knife radiosurgery for patients with single and multiple brain metastases. Cancer J Sci Am 2:335–342, 1996
Somaza S, Kondziolka D, Lunsford LD, Kirkwood JM, Flickinger JC: Stereotactic radiosurgery for cerebral metastatic melanoma. J Neurosurg 79:661–666, 1993
Loeffler JS, Alexander E: Radiosurgery for the treatment of intracranial metastases. In Stereotactic Radiosurgery. E Alexander, JS Loeffler, D Lunsford (eds). New York, McGraw-Hill, 1993
Shaw E, Scott C, Souhami L, Dinapoli R, Bahary JP, Kline R, et al.: Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: Initial report of Radiation Therapy Oncology Group protocol (90–05). Int J Radiat Oncol Biol Phys 34:647–654, 1996
Mehta MP, Noyes WR, Craig B, Lamond J, Auchter R, French M, et al.: A cost-effectiveness and cost-utility analysis of radiosurgery versus resection for single brain metastases. Int J Radiat Oncol Biol Phys 39:445–454, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mehta, M.P., Boyd, T.S. & Sinha, P. The Status of Stereotactic Radiosurgery for Cerebral Metastases in 1998. Journal of Radiosurgery 1, 17–30 (1998). https://doi.org/10.1023/B:JORA.0000010873.43368.21
Issue Date:
DOI: https://doi.org/10.1023/B:JORA.0000010873.43368.21